Try our Advanced Search for more refined results

FDA Accuses 2 Drug Cos. Of Marketing Unapproved Opioid

By Dani Kass ( September 16, 2016, 6:06 PM EDT) -- Durect Corp. and Pain Therapeutics Inc. are violating the Food, Drug and Cosmetic Act by making statements about the safety and effectiveness of their opioid painkiller Remoxy ER before it's been approved the U.S. Food and Drug Administration, the agency said in a letter published Wednesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!